The risk analysis expanded the cell types that correlated with AD development, revealed that Gran, InN, OPCs, NPC, and Pyra had a high correlation with AD, giving a clue to new research direction for clinical treatment. This evidence concerns the gene NPC1 and Alzheimer disease.